Jaume J
Cancers (Basel). 2025; 17(5).
PMID: 40075642
PMC: 11899416.
DOI: 10.3390/cancers17050794.
Nguyen N, Muller R, Briukhovetska D, Weber J, Feucht J, Kunkele A
Cancers (Basel). 2024; 16(14).
PMID: 39061247
PMC: 11274444.
DOI: 10.3390/cancers16142608.
Nanajian A, Scott M, Burcus N, Ruedlinger B, Oshin E, Beebe S
Vaccines (Basel). 2024; 12(6).
PMID: 38932362
PMC: 11209453.
DOI: 10.3390/vaccines12060633.
Ma S, Barr T, Yu J
Cancer Treat Res. 2023; 190:49-94.
PMID: 38112999
DOI: 10.1007/978-3-031-45654-1_3.
Keisari Y, Kelson I
Cancer Metastasis Rev. 2023; 42(4):1065-1068.
PMID: 37952066
PMC: 10713665.
DOI: 10.1007/s10555-023-10150-x.
Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology.
Hambly J, Ruby C, Mourich D, Bracha S, Dolan B
Vet Sci. 2023; 10(5).
PMID: 37235419
PMC: 10224056.
DOI: 10.3390/vetsci10050336.
Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies.
Fox B, Urba W, Jensen S, Page D, Curti B, Sanborn R
Clin Cancer Res. 2023; 29(12):2173-2175.
PMID: 37040070
PMC: 10261915.
DOI: 10.1158/1078-0432.CCR-23-0422.
Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
Nin D, Deng L
Cells. 2023; 12(6).
PMID: 36980267
PMC: 10047177.
DOI: 10.3390/cells12060926.
Novel Mouse Models for Cancer Immunology.
Connolly K, Fitzgerald B, Damo M, Joshi N
Annu Rev Cancer Biol. 2023; 6(1):269-291.
PMID: 36875867
PMC: 9979244.
DOI: 10.1146/annurev-cancerbio-070620-105523.
Portrait of an autologous cancer vaccine: Then and now.
Berd D
Hum Vaccin Immunother. 2023; 19(1):2172925.
PMID: 36755486
PMC: 10012894.
DOI: 10.1080/21645515.2023.2172925.
Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.
Alarcon N, Jaramillo M, Mansour H, Sun B
Pharmaceutics. 2022; 14(7).
PMID: 35890342
PMC: 9325128.
DOI: 10.3390/pharmaceutics14071448.
Vaccines for immunoprevention of DNA mismatch repair deficient cancers.
Hernandez-Sanchez A, Grossman M, Yeung K, Sei S, Lipkin S, Kloor M
J Immunother Cancer. 2022; 10(6).
PMID: 35732349
PMC: 9226910.
DOI: 10.1136/jitc-2021-004416.
Immunotherapy in non-small cell lung cancer: rationale, recent advances and future perspectives.
Luo W, Wang Z, Zhang T, Yang L, Xian J, Li Y
Precis Clin Med. 2022; 4(4):258-270.
PMID: 35692863
PMC: 8982543.
DOI: 10.1093/pcmedi/pbab027.
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?.
Aran A, Garrigos L, Curigliano G, Cortes J, Marti M
Cancers (Basel). 2022; 14(7).
PMID: 35406543
PMC: 8996954.
DOI: 10.3390/cancers14071771.
Agents of cancer immunosurveillance: HSPs and dsDNA.
Nayak D, Binder R
Trends Immunol. 2022; 43(5):404-413.
PMID: 35382994
PMC: 9058224.
DOI: 10.1016/j.it.2022.03.004.
mA Regulator-Mediated Methylation Modification Patterns and Characterisation of Tumour Microenvironment Infiltration in Non-Small Cell Lung Cancer.
Fan Y, Zhou Y, Lou M, Li X, Zhu X, Yuan K
J Inflamm Res. 2022; 15:1969-1989.
PMID: 35356071
PMC: 8958726.
DOI: 10.2147/JIR.S356841.
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy.
Staudt R, Carlson R, Snook A
Cancer Biol Ther. 2022; 23(1):127-133.
PMID: 35129050
PMC: 8820794.
DOI: 10.1080/15384047.2022.2033057.
Identification of neoantigens for individualized therapeutic cancer vaccines.
Lang F, Schrors B, Lower M, Tureci O, Sahin U
Nat Rev Drug Discov. 2022; 21(4):261-282.
PMID: 35105974
PMC: 7612664.
DOI: 10.1038/s41573-021-00387-y.
The foundations of immune checkpoint blockade and the ipilimumab approval decennial.
Korman A, Garrett-Thomson S, Lonberg N
Nat Rev Drug Discov. 2021; 21(7):509-528.
PMID: 34937915
DOI: 10.1038/s41573-021-00345-8.
A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Check J, Check D
Int J Mol Sci. 2021; 22(22).
PMID: 34830233
PMC: 8621132.
DOI: 10.3390/ijms222212351.
